LNAI — Lunai Bioworks Share News
0.000.00%
Last trade - 00:00- $1.48m
- $0.76m
- $0.05m
Brief: Enochian Biosciences Names The Hon. Dr. Mark Dybul As Chief Executive Officer
U.S. STOCKS ON THE MOVE-Tempest Therapeutics, Celldex Therapeutics, 23andMe, Didi
Enochian Biosciences up after FDA accepts request to review potential hepatitis B cure
Brief: Enochian Biosciences Announces FDA Acceptance Of Pre-IND Request For Potential Cure For Hepatitis B Virus Infection
Brief: Enochian Biosciences Inc - Acquired Exclusive License For Innovative Technology To Potentially Treat And Prevent All Variants Of Coronavirus
Brief: Enochian Biosciences Announces Acquisition Of Exclusive License For Potential Pan-Coronavirus And Pan-Influenza Inhaled Treatment And Prevention Technology
Brief: Enochian Biosciences Announces $29 Million Registered Direct Offering
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:53 PM
U.S. STOCKS ON THE MOVE-Lordstown Motors, RAPT Therapeutics, AMC Entertainment
Enochian Biosciences surges as FDA accepts request to review potential HIV cure
Brief: Enochian Biosciences Announces FDA Acceptance Of Pre-Ind Request For Potential Hiv Cure
Brief: Enochian Biosciences Announces FDA Acceptance Of Pre-Ind Request For Potential Hiv Cure
Brief: Enochian Biosciences Inc - On April 18, Entered Into A Statement Of Work & License Agreement With G Tech Bio, And G Health Research Foundation
Brief: Enochian Biosciences Says Co Entered Into Purchase Agreement With Lincoln Park Capital Fund LLC
Brief: Enochian Biosciences Inc Files For Stock Shelf Of Upto $50 Million
U.S. STOCKS ON THE MOVE-Boeing, Chesapeake Energy, Ideanomics
Enochian BioSciences surges on advancing potential HIV treatment
Brief: Enochian Biosciences Announces Successful Completion Of FDA Interact Meeting For Potential Cure For HIV
U.S. STOCKS ON THE MOVE-Neonode, Enochian, Aviat Networks